About Macrocure Ltd (MCUR)
MacroCure Ltd. is a biotechnology company. The Company is focused on developing, manufacturing and commercializing cell therapy products to address unmet needs for the treatment of chronic wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). Its product candidate, CureXcell, is a combination of living human white blood cells that have been activated to facilitate the healing process and stimulate wound closure. CureXcell is in Phase III. Its CureXcell addresses each phase of healing in the impaired wound, including the production of growth factors and other biochemical factors involved in fibroblast activation, cell migration and extracellular matrix production, stimulating the body's natural healing process. Its delivery method of direct superficial injection into the chronic wound allows the precise delivery of the cells into the defective wound tissue where they can be effective.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: MCUR
- CUSIP: N/A
- Previous Close: $1.51
- 50 Day Moving Average: $1.51
- 200 Day Moving Average: $1.54
- 52-Week Range: $0.75 - $3.20
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -4.72
- P/E Growth: 0.00
- Market Cap: $N/A
- Beta: 0.62
Companies Related to Macrocure Ltd:
Earnings History for Macrocure Ltd (NASDAQ:MCUR)Earnings History by Quarter for Macrocure Ltd (NASDAQ:MCUR)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/16/2016|| || || || || || || || |
Earnings Estimates for Macrocure Ltd (NASDAQ:MCUR)
Current Year EPS Consensus Estimate: $-0.32 EPS
Next Year EPS Consensus Estimate: $-0.32 EPS
Dividend History for Macrocure Ltd (NASDAQ:MCUR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Macrocure Ltd (NASDAQ:MCUR)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Macrocure Ltd (NASDAQ:MCUR)
Latest Headlines for Macrocure Ltd (NASDAQ:MCUR)
Frequently Asked Questions for Macrocure Ltd (NASDAQ:MCUR)
What is Macrocure Ltd's stock symbol?
Macrocure Ltd trades on the NASDAQ under the ticker symbol "MCUR."
How were Macrocure Ltd's earnings last quarter?
Macrocure Ltd (NASDAQ:MCUR) released its quarterly earnings data on Tuesday, November, 17th. The company reported ($0.32) EPS for the quarter, beating analysts' consensus estimates of ($0.36) by $0.04.
When will Macrocure Ltd make its next earnings announcement?
Macrocure Ltd is scheduled to release their next quarterly earnings announcement on Wednesday, March, 16th 2016.
Where is Macrocure Ltd's stock going? Where will Macrocure Ltd's stock price be in 2017?
1 analysts have issued 12-month target prices for Macrocure Ltd's shares. Their predictions range from $1.00 to $1.00. On average, they anticipate Macrocure Ltd's stock price to reach $1.00 in the next twelve months.
Who owns Macrocure Ltd stock?
Macrocure Ltd's stock is owned by a number of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.00%).
Who bought Macrocure Ltd stock? Who is buying Macrocure Ltd stock?
Macrocure Ltd's stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.
How do I buy Macrocure Ltd stock?
Shares of Macrocure Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Macrocure Ltd stock cost?
One share of Macrocure Ltd stock can currently be purchased for approximately $1.51.
Macrocure Ltd (MCUR) Chart for Saturday, March, 25, 2017